PTC THERAPEUTICS, INC. — Director's Dealing 2016

Jan 7, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2016-01-04

Reporting Person: McDonough Cameron Geoffrey (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-01-04	Stock Option (right to buy)	$30.86	A	12000	Acquired	2026-01-03	Common Stock (12000)	Direct

Footnotes

F1: This option was granted on January 4, 2016 and vests over one year in twelve equal monthly installments, commencing on February 4, 2016.